These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6868490)

  • 1. [Effect of riboxin on hemodynamics and microcirculation in patients with chronic ischemic heart disease].
    Bondarenko IP
    Vrach Delo; 1983 Jan; (1):15-8. PubMed ID: 6868490
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of riboxin on visual function in glaucoma patients (experimental clinical study)].
    Iakovlev AA; Konde LA
    Vestn Oftalmol; 1982; (5):10-2. PubMed ID: 7147539
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of riboxin on lipid peroxidation in patients with acute myocardial infarct].
    Rudyk BI; Shved NI; Blinova NG; Sabadyshin RA; Gerasimets IM
    Vrach Delo; 1989 Aug; (8):14-5. PubMed ID: 2588512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Riboxin treatment of peptic ulcer patients].
    Dorofeev GI; Sonina SI; Luft VM; Lisochkin BG; Marina AP
    Vrach Delo; 1984 Feb; (2):86-8. PubMed ID: 6719882
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of riboxin in the complex treatment of patients with acute pneumonia].
    Borovkova MS; Neĭko EM
    Vrach Delo; 1988 Apr; (4):85-7. PubMed ID: 3400234
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mechanism of the effect of riboxin].
    Kukes VG; Forova NM; Burian EF; Gneushev ET; Saprykina TD
    Sov Med; 1983; (2):84-6. PubMed ID: 6857353
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of kordaron, anaprilin, dimedrol and riboxin on the hemodynamic effects of strophanthin in experimental heart failure].
    Gendenshteĭn EI; Lemkina SM
    Farmakol Toksikol; 1988; 51(2):53-6. PubMed ID: 3378606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical efficacy and outlook for the use of new drugs for metabolic therapy in dermatology].
    Kubanova AA; Khamaganova IV
    Vestn Dermatol Venerol; 1989; (3):57-60. PubMed ID: 2741548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The riboxin treatment of workers in the electron vacuum tube industry suffering from dermatoses].
    Shulipa IV; Turkevich IuN; Zaĭchenko AI
    Vestn Dermatol Venerol; 1990; (3):39-41. PubMed ID: 2142361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The results of the use of riboxin in the combined treatment of patients with pulmonary tuberculosis].
    Aleksandrova AE; Borisova LE; Vasil'ev AV
    Probl Tuberk; 1989; (9):28-33. PubMed ID: 2511573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy of quinazopyrine, preparation E and riboxin in experimental myocardial infarct].
    Stets VR; Tishkin VS; Evdokimov EI
    Vrach Delo; 1989 Dec; (12):13-4. PubMed ID: 2483471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of antioxidant therapy on lipid peroxidation in patients with acute and protracted pneumonia].
    Borovkova MS; Mashchakevich II
    Klin Med (Mosk); 1988 Dec; 66(12):62-4. PubMed ID: 3230853
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of a course of pentoxifylline (trental) treatment on microcirculatory and central hemodynamic functions in chronic ischemic heart disease patients].
    Atroshchenko ES
    Ter Arkh; 1985; 57(1):43-6. PubMed ID: 3983842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microcirculation in chronic ischemic heart disease and the effects of nitroglycerin on microcirculation].
    Agapova EN; Eliseeva LN
    Ter Arkh; 1980; 52(11):100-4. PubMed ID: 6781086
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ultrastructural bases for cardiovascular insufficiency in experimental chronic pneumonia].
    Kiseleva AF; Stechenko LA; Krechkovskiĭ EA; Andreenko TV; Volynets VV
    Vrach Delo; 1981 Aug; (8):49-52. PubMed ID: 7271956
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of complamine on various indicators of hemostasis and microcirculation in chronic ischemic heart disease].
    Bol'shakova RM; Dukhina MA; Furkalo NK; Solovtsova KM; Progonnaia VV
    Vrach Delo; 1978 Jan; (1):36-40. PubMed ID: 625941
    [No Abstract]   [Full Text] [Related]  

  • 17. [The mechanism of action of riboxin].
    Dunaev VV; Tishkin VS; Evdokimov EI; Belaĭ IM
    Farmakol Toksikol; 1989; 52(6):56-8. PubMed ID: 2483141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacodynamics of riboxin (inosine)].
    Frantsuzova SB; Krivelevich VIa; Parkhoniuk VP
    Farmakol Toksikol; 1989; 52(1):115-8. PubMed ID: 2651150
    [No Abstract]   [Full Text] [Related]  

  • 19. [The role of the sympathomimetic activity of beta-adrenergic blockaders in the treatment of patients with chronic ischemic heart disease].
    Ol'binskaia LI; Bragina GI
    Ter Arkh; 1983; 55(9):35-40. PubMed ID: 6138864
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of riboxin in treating patients with chronic ischemic heart disease].
    Lanovaia NI; Neĭko EM
    Vrach Delo; 1986 Aug; (8):17-9. PubMed ID: 3776150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.